Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bioventus (BVS)
NASDAQ:BVS
Holding BVS?
Track your performance easily
Earnings Data
Report Date
Mar 20, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.08Last Year’s EPS
$0.07Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 05, 2024
|% Change Since: -22.17%
|Next Earnings Date:Mar 20, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with significant revenue growth, improved profitability, and enhanced liquidity. Despite some supply chain challenges and expected lower growth in Q4 due to past favorable comparisons, the company remains optimistic about its strategic direction and financial outlook.Company Guidance
During the Bioventus Third Quarter 2024 Earnings Call, the company announced strong financial performance and updated its full-year guidance. Revenue for Q3 reached $139 million, marking a 15% increase compared to the prior year, driven by double-digit growth in both Pain Treatments and Surgical Solutions. The company's adjusted EBITDA grew to $24 million, which is an 8% increase from the previous year, and they highlighted a year-to-date adjusted EBITDA growth of 21%. The adjusted gross margin remained strong at 75%. For the full year, Bioventus raised its net sales guidance to a range of $562 million to $567 million, reflecting expected revenue growth of nearly 13%, and adjusted earnings per share are now projected to be between $0.40 and $0.42. The company also reaffirmed its commitment to expanding its adjusted EBITDA margin by at least 100 basis points annually. Additionally, Bioventus reported a reduction in its net leverage ratio to 3.5x and expects further improvements in cash flow and financial position heading into 2025.Strong Revenue Growth
Revenue of $139 million increased by 15% compared to the prior year, marking the fourth consecutive quarter of double-digit organic revenue growth. Pain Treatments and Surgical Solutions both experienced double-digit growth.
Increased Financial Guidance
Bioventus raised its full-year revenue guidance to the high end of previous expectations, with net sales now expected to be between $562 million and $567 million, representing a $2.5 million increase at the midpoint.
Profitability Improvements
Adjusted EBITDA of $24 million increased by $2 million versus the prior year, with nearly 150 basis points of adjusted EBITDA margin improvement. Adjusted earnings per share guidance increased to between $0.40 and $0.42.
Positive Cash Flow and Reduced Leverage
Bioventus generated positive cash flow from operations in the third quarter, increased its cash position, and reduced its net leverage ratio to approximately 3.5 turns.
Strategic Divestiture
Announced the agreement to sell the advanced rehabilitation business for $25 million with potential earnouts up to $20 million, expected to enhance focus on core portfolio and liquidity.
---
BVS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BVS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 05, 2024 | $13.71 | $11.48 | -16.27% |
| Aug 06, 2024 | $6.26 | $8.09 | +29.23% |
| May 07, 2024 | $4.00 | $5.12 | +28.00% |
| Mar 12, 2024 | $5.31 | $5.60 | +5.46% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Bioventus (BVS) report earnings?
Bioventus (BVS) is schdueled to report earning on Mar 20, 2025, TBA Not Confirmed.
What is Bioventus (BVS) earnings time?
Bioventus (BVS) earnings time is at Mar 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BVS EPS forecast?
BVS EPS forecast for the fiscal quarter 2024 (Q4) is $0.08.
---